Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic lymphocytes (1 trial)
autologous hematopoietic stem cells (1 trial)
cyclosporine (sandimmune) (1 trial)
fludarabine (fludara) (1 trial)
mycophenolate (CellCept) (1 trial)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Trials (1 total)
Trial APIs (5 total)